The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

PE-backed specialty pharma company Kelso Pharma, which recently acquired Italian medical device and pharma company Velit ...

Buoyed by the breakthrough technologies and methodologies that have enabled earlier intervention, Alzheimer’s drug developers ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...